Ipsen Future Growth

Future criteria checks 2/6

Ipsen is forecast to grow earnings and revenue by 7% and 5.5% per annum respectively. EPS is expected to grow by 6.9% per annum. Return on equity is forecast to be 14.8% in 3 years.

Key information

7.0%

Earnings growth rate

6.9%

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth rate5.5%
Future return on equity14.8%
Analyst coverage

Good

Last updated04 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0MH6 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,9328028481,10911
12/31/20253,6867307941,02012
12/31/20243,49062763084913
6/30/20243,435664425903N/A
3/31/20243,371641554884N/A
12/31/20233,306617683866N/A
6/30/20233,282406764972N/A
3/31/20233,219500741971N/A
12/31/20223,156593719971N/A
9/30/20223,053656615972N/A
6/30/20222,950719512973N/A
3/31/20222,849675494933N/A
12/31/20212,749631475893N/A
9/30/20212,712626570860N/A
6/30/20212,676622665827N/A
3/31/20212,681585649799N/A
12/31/20202,686548632771N/A
9/30/20202,697249564750N/A
6/30/20202,707-50496729N/A
3/31/20202,700-53421678N/A
12/31/20192,693-55347628N/A
9/30/20192,605176310591N/A
6/30/20192,516406272555N/A
3/31/20192,432397279563N/A
12/31/20182,348388285571N/A
9/30/20182,258365N/AN/AN/A
6/30/20182,167343280502N/A
3/31/20182,090307N/A463N/A
12/31/20172,012270N/A423N/A
9/30/20171,923243N/AN/AN/A
6/30/20171,834217N/A316N/A
3/31/20171,753221N/A317N/A
12/31/20161,671226N/A318N/A
9/30/20161,623229N/AN/AN/A
6/30/20161,575233N/A318N/A
3/31/20161,548211N/A271N/A
12/31/20151,520189N/A224N/A
9/30/20151,468165N/A225N/A
6/30/20151,416140N/A227N/A
3/31/20151,374147N/A237N/A
12/31/20141,332154N/A246N/A
9/30/20141,310155N/A217N/A
6/30/20141,287156N/A188N/A
3/31/20141,284149N/A188N/A
12/31/20131,282142N/A188N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0MH6's forecast earnings growth (7% per year) is above the savings rate (2.1%).

Earnings vs Market: 0MH6's earnings (7% per year) are forecast to grow slower than the UK market (14.6% per year).

High Growth Earnings: 0MH6's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0MH6's revenue (5.5% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0MH6's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0MH6's Return on Equity is forecast to be low in 3 years time (14.8%).


Discover growth companies